☰

Paul Cumming - Publications

Affiliations: 
Biological Psychiatry Ludwig Maximilians University, München, Bayern, Germany 
Area:
Dopamine, Imaging
Tree Info Grants Similar researchers PubMed Report error

215/372 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z, Zuo C, Guan Y, Zhao Q, Rominger A. Associations of [F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism. Frontiers in Neuroscience. 14: 604. PMID 32694971 DOI: 10.3389/Fnins.2020.00604  0.385
2020 Han X, Wu P, Alberts I, Zhou H, Yu H, Bargiotas P, Yakushev I, Wang J, Höglinger G, Förster S, Bassetti C, Oertel W, Schwaiger M, Huang SC, Cumming P, et al. Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder. Neuroimage. Clinical. 27: 102294. PMID 32570206 DOI: 10.1016/J.Nicl.2020.102294  0.307
2020 Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Cumming P, et al. Asymmetry of fibrillar plaque burden in amyloid mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32414948 DOI: 10.2967/Jnumed.120.242750  0.315
2020 Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D receptor agonist radioligand study. Translational Psychiatry. 10: 2. PMID 32066718 DOI: 10.1038/S41398-019-0681-5  0.366
2020 Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J, Cumming P, Rominger A. Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 31985461 DOI: 10.3233/Jad-190818  0.311
2019 Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, ... ... Cumming P, et al. Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31840326 DOI: 10.1002/Mds.27945  0.407
2019 Cumming P, Marton J, Lilius TO, Olberg DE, Rominger A. A Survey of Molecular Imaging of Opioid Receptors. Molecules (Basel, Switzerland). 24. PMID 31752279 DOI: 10.3390/Molecules24224190  0.338
2019 Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A, Griesinger C, Zwergal A, Levin J, Bartenstein P, Yakushev I, ... Cumming P, et al. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. Alzheimer's Research & Therapy. 11: 67. PMID 31370885 DOI: 10.1186/S13195-019-0522-Z  0.339
2019 Kim JH, Choe YS, Cumming P, Son YD, Kim HK, Joo YH, Kim JH. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: an [ F]fallypride PET and fMRI study. Synapse (New York, N.Y.). PMID 31206840 DOI: 10.1002/Syn.22121  0.36
2019 Gründer G, Cumming P. The downside of downregulation. Brain : a Journal of Neurology. 142: 1500-1502. PMID 31135045 DOI: 10.1093/Brain/Awz133  0.315
2018 Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. Molecular Imaging. 17: 1536012118792317. PMID 30203712 DOI: 10.1177/1536012118792317  0.351
2018 Kim JH, Cumming P, Son YD, Kim HK, Joo YH, Kim JH. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [ F]fallypride PET and functional MRI study. Synapse (New York, N.Y.). PMID 30063263 DOI: 10.1002/Syn.22064  0.377
2018 Amato D, Canneva F, Cumming P, Maschauer S, Groos D, Dahlmanns JK, Grömer TW, Chiofalo L, Dahlmanns M, Zheng F, Kornhuber J, Prante O, Alzheimer C, von Hörsten S, Müller CP. A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Molecular Psychiatry. PMID 30038229 DOI: 10.1038/S41380-018-0114-5  0.32
2018 Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G. The role of striatal dopamine D receptors in cognitive performance in drug-free patients with schizophrenia. Psychopharmacology. PMID 29717334 DOI: 10.1007/S00213-018-4916-6  0.324
2017 Cumming P, Burgher B, Patkar O, Breakspear M, Vasdev N, Thomas P, Liu GJ, Banati R. Sifting through the surfeit of neuroinflammation tracers. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17748786. PMID 29256293 DOI: 10.1177/0271678X17748786  0.406
2017 Kanthan M, Cumming P, Hooker JM, Vasdev N. Classics in Neuroimaging: Imaging the Dopaminergic Pathway with PET. Acs Chemical Neuroscience. PMID 28719177 DOI: 10.1021/Acschemneuro.7B00252  0.403
2016 Cumming P, Gallinat J. Invited commentary: mapping the alteration in glutamate with GluCEST MRI in a mouse model of dopamine deficiency: An Editorial Highlight for 'Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency'. Journal of Neurochemistry. PMID 27747879 DOI: 10.1111/Jnc.13759  0.303
2016 Deutschländer A, la Fougère C, Boetzel K, Albert NL, Gildehaus FJ, Bartenstein P, Xiong G, Cumming P. Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients. Neuroimage. Clinical. 12: 41-6. PMID 27408789 DOI: 10.1016/J.Nicl.2016.06.007  0.427
2016 Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nuclear Medicine and Biology. 43: 478-489. PMID 27236283 DOI: 10.1016/J.Nucmedbio.2016.05.003  0.383
2016 Cumming P, Gryglewski G, Kranz GS, Lanzenberger R. Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. Journal of Affective Disorders. 199: 21-22. PMID 27057649 DOI: 10.1016/J.Jad.2016.03.058  0.324
2016 Cumming P. A business of some heat: molecular imaging of phosphodiesterase 5. Journal of Neurochemistry. 136: 220-1. PMID 26990291 DOI: 10.1111/Jnc.13453  0.396
2015 Rademacher L, Prinz S, Winz O, Henkel K, Dietrich CA, Schmaljohann J, Mohammadkhani Shali S, Schabram I, Stoppe C, Cumming P, Hilgers RD, Kumakura Y, Coburn M, Mottaghy FM, Gründer G, et al. Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers. Biological Psychiatry. PMID 26803340 DOI: 10.1016/J.Biopsych.2015.11.009  0.331
2015 Schlüter T, Winz O, Henkel K, Eggermann T, Mohammadkhani-Shali S, Dietrich C, Heinzel A, Decker M, Cumming P, Zerres K, Piel M, Mottaghy FM, Vernaleken I. MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males. Neuroimage. 125: 378-385. PMID 26481676 DOI: 10.1016/J.Neuroimage.2015.10.031  0.347
2015 Maschauer S, Haller A, Riss PJ, Kuwert T, Prante O, Cumming P. Specific binding of [(18) F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain. Journal of Neurochemistry. PMID 26386360 DOI: 10.1111/Jnc.13370  0.438
2015 Geisler S, Beindorff N, Cremer M, Hoffmann K, Brenner W, Cumming P, Meyer PT, Langen KJ, Fuchs E, Buchert R. Characterization of [(123) I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography. Synapse (New York, N.Y.). 69: 497-504. PMID 26126942 DOI: 10.1002/Syn.21838  0.422
2015 Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus FJ, Carlsen J, Cumming P, Baumann K, Haass C, Steiner H, Bartenstein P, Herms J, Rominger A. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. Plos One. 10: e0116678. PMID 25706990 DOI: 10.1371/Journal.Pone.0116678  0.318
2015 Vafaee MS, Gjedde A, Imamirad N, Vang K, Chakravarty MM, Lerch JP, Cumming P. Smoking normalizes cerebral blood flow and oxygen consumption after 12-hour abstention. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 699-705. PMID 25605288 DOI: 10.1038/Jcbfm.2014.246  0.305
2015 Deserno L, Beck A, Huys QJ, Lorenz RC, Buchert R, Buchholz HG, Plotkin M, Kumakara Y, Cumming P, Heinze HJ, Grace AA, Rapp MA, Schlagenhauf F, Heinz A. Chronic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatum. The European Journal of Neuroscience. 41: 477-86. PMID 25546072 DOI: 10.1111/Ejn.12802  0.317
2015 Cumming P, Maschauer S, Riss PJ, Grill E, Pischetsrieder M, Kuwert T, Prante O. Perturbed Development of Striatal Dopamine Transporters in Fatty Versus Lean Zucker Rats: a Follow-up Small Animal PET Study. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 521-8. PMID 25537092 DOI: 10.1007/S11307-014-0811-7  0.397
2015 Cumming P, Skaper D, Kuwert T, Maschauer S, Prante O. Detection of monoamine oxidase a in brain of living rats with [18F]fluoroethyl-harmol PET. Synapse (New York, N.Y.). 69: 57-9. PMID 25229748 DOI: 10.1002/Syn.21785  0.384
2014 Jansen NL, Feuerecker R, Becker-Bense S, Zwergal A, Wulff M, Xiong G, Wängler B, Cumming P, Bartenstein P, Dieterich M, la Fougère C. Assessment of cerebral dopamine D 2/3 formula-receptors in patients with bilateral vestibular failure. Journal of Vestibular Research : Equilibrium & Orientation. 24: 403-13. PMID 25564083 DOI: 10.3233/Ves-140526  0.361
2014 Schabram I, Henkel K, Mohammadkhani Shali S, Dietrich C, Schmaljohann J, Winz O, Prinz S, Rademacher L, Neumaier B, Felzen M, Kumakura Y, Cumming P, Mottaghy FM, Gründer G, Vernaleken I. Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14769-76. PMID 25355228 DOI: 10.1523/Jneurosci.1560-14.2014  0.423
2014 Lehner S, Todica A, Vanchev Y, Uebleis C, Wang H, Herrler T, Wängler C, Cumming P, Böning G, Franz WM, Bartenstein P, Hacker M, Brunner S. In vivo monitoring of parathyroid hormone treatment after myocardial infarction in mice with [68Ga]annexin A5 and [18F]fluorodeoxyglucose positron emission tomography. Molecular Imaging. 13. PMID 25249170 DOI: 10.2310/7290.2014.00035  0.319
2014 Cumming P. Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis. Journal of Neurochemistry. 131: 541-5. PMID 25156194 DOI: 10.1111/Jnc.12848  0.334
2014 Rötering S, Deuther-Conrad W, Cumming P, Donat CK, Scheunemann M, Fischer S, Xiong G, Steinbach J, Peters D, Sabri O, Bucerius J, Brust P. Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490. Ejnmmi Research. 4: 43. PMID 25136512 DOI: 10.1186/S13550-014-0043-5  0.363
2014 Gryglewski G, Lanzenberger R, Kranz GS, Cumming P. Meta-analysis of molecular imaging of serotonin transporters in major depression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 1096-103. PMID 24802331 DOI: 10.1038/Jcbfm.2014.82  0.307
2014 Cumming P, Maschauer S, Riss PJ, Tschammer N, Fehler SK, Heinrich MR, Kuwert T, Prante O. Radiosynthesis and validation of ¹⁸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 1148-56. PMID 24714035 DOI: 10.1038/Jcbfm.2014.63  0.447
2014 Hocke C, Cumming P, Maschauer S, Kuwert T, Gmeiner P, Prante O. Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor. Nuclear Medicine and Biology. 41: 223-8. PMID 24480780 DOI: 10.1016/J.Nucmedbio.2013.12.014  0.447
2014 Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, Price JL, Cornell ME, McConathy JE, Gangwani S, Sheline YI. Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study. Psychiatry Research. 221: 231-9. PMID 24468015 DOI: 10.1016/J.Pscychresns.2014.01.003  0.411
2014 Smits R, Fischer S, Hiller A, Deuther-Conrad W, Wenzel B, Patt M, Cumming P, Steinbach J, Sabri O, Brust P, Hoepping A. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 22: 804-12. PMID 24369841 DOI: 10.1016/J.Bmc.2013.12.011  0.321
2014 Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, Mille E, Gildehaus FJ, Cumming P, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. Neuroimage. 84: 843-53. PMID 24055703 DOI: 10.1016/J.Neuroimage.2013.09.017  0.394
2014 Cumming P. PET neuroimaging: the white elephant packs his trunk? Neuroimage. 84: 1094-100. PMID 23959198 DOI: 10.1016/J.Neuroimage.2013.08.020  0.334
2013 Schlüter T, Winz O, Henkel K, Prinz S, Rademacher L, Schmaljohann J, Dautzenberg K, Cumming P, Kumakura Y, Rex S, Mottaghy FM, Gründer G, Vernaleken I. The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16889-96. PMID 24155295 DOI: 10.1523/Jneurosci.1398-13.2013  0.386
2013 Kalbitzer J, Kalbitzer U, Knudsen GM, Cumming P, Heinz A. How the cerebral serotonin homeostasis predicts environmental changes: a model to explain seasonal changes of brain 5-HTT as intermediate phenotype of the 5-HTTLPR. Psychopharmacology. 230: 333-43. PMID 24150247 DOI: 10.1007/S00213-013-3308-1  0.306
2013 Kumakura Y, Gjedde A, Caprioli D, Kienast T, Beck A, Plotkin M, Schlagenhauf F, Vernaleken I, Gründer G, Bartenstein P, Heinz A, Cumming P. Increased turnover of dopamine in caudate nucleus of detoxified alcoholic patients. Plos One. 8: e73903. PMID 24040111 DOI: 10.1371/Journal.Pone.0073903  0.399
2013 Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. The International Journal of Cardiovascular Imaging. 29: 1645-53. PMID 23744128 DOI: 10.1007/S10554-013-0254-2  0.315
2013 Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, et al. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1127-34. PMID 23729696 DOI: 10.2967/Jnumed.112.114660  0.38
2013 Rominger A, Cumming P, Xiong G, Koller G, Förster S, Zwergal A, Karamatskos E, Bartenstein P, La Fougère C, Pogarell O. Effects of acute detoxification of the herbal blend 'Spice Gold' on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1606-10. PMID 23452563 DOI: 10.1016/J.Euroneuro.2013.01.009  0.437
2013 Fischer S, Hiller A, Smits R, Hoepping A, Funke U, Wenzel B, Cumming P, Sabri O, Steinbach J, Brust P. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 74: 128-36. PMID 23416407 DOI: 10.1016/J.Apradiso.2013.01.002  0.337
2013 Todica A, Brunner S, Böning G, Lehner S, Nekolla SG, Wildgruber M, Ãœbleis C, Wängler C, Sauter M, Klingel K, Cumming P, Bartenstein P, Schirrmacher R, Franz WM, Hacker M. [68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy: comparison with cardiac MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 441-9. PMID 23408338 DOI: 10.1007/S11307-013-0618-Y  0.31
2013 Jupp B, Caprioli D, Saigal N, Reverte I, Shrestha S, Cumming P, Everitt BJ, Robbins TW, Dalley JW. Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. The European Journal of Neuroscience. 37: 1519-28. PMID 23368520 DOI: 10.1111/Ejn.12146  0.352
2013 Kienast T, Schlagenhauf F, Rapp MA, Wrase J, Daig I, Buchholz HG, Smolka MN, Gründer G, Kumakura Y, Cumming P, Charlet K, Bartenstein P, Hariri AR, Heinz A. Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients. Pharmacopsychiatry. 46: 130-6. PMID 23364872 DOI: 10.1055/S-0032-1331747  0.329
2013 Walter B, Eiselt M, Cumming P, Xiong G, Hinz R, Uthe S, Brust P, Bauer R. Resistance of brain glucose metabolism to thiopental-induced CNS depression in newborn piglets. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 31: 157-64. PMID 23305916 DOI: 10.1016/J.Ijdevneu.2012.12.008  0.377
2013 Todica A, Böning G, Lehner S, Weidl E, Cumming P, Wängler C, Nekolla SG, Schwaiger M, Bartenstein P, Schirrmacher R, Hacker M. Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 20: 262-74. PMID 23255241 DOI: 10.1007/S12350-012-9663-1  0.326
2013 Cumming P, Xiong G, la Fougère C, Rominger A, Bartenstein P, Buchholz HG, Piel M, Rösch F, Gründer G, Vernaleken I. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum. Synapse (New York, N.Y.). 67: 199-203. PMID 23239525 DOI: 10.1002/Syn.21630  0.443
2013 Vernaleken I, Klomp M, Moeller O, Raptis M, Nagels A, Rösch F, Schaefer WM, Cumming P, Gründer G. Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 745-54. PMID 22906553 DOI: 10.1017/S1461145712000764  0.442
2013 Schlagenhauf F, Rapp MA, Huys QJ, Beck A, Wüstenberg T, Deserno L, Buchholz HG, Kalbitzer J, Buchert R, Bauer M, Kienast T, Cumming P, Plotkin M, Kumakura Y, Grace AA, et al. Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. Human Brain Mapping. 34: 1490-9. PMID 22344813 DOI: 10.1002/Hbm.22000  0.337
2012 Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro-Oncology. 14: 1473-80. PMID 23090986 DOI: 10.1093/Neuonc/Nos259  0.302
2012 Lehner S, Todica A, Brunner S, Uebleis C, Wang H, Wängler C, Herbach N, Herrler T, Böning G, Laubender RP, Cumming P, Schirrmacher R, Franz W, Hacker M. Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice. Molecular Imaging. 11: 461-70. PMID 23084247 DOI: 10.2310/7290.2012.00010  0.327
2012 Brunner S, Todica A, Böning G, Nekolla SG, Wildgruber M, Lehner S, Sauter M, Ubleis C, Klingel K, Cumming P, Franz WM, Hacker M. Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy. Ejnmmi Research. 2: 43. PMID 22863174 DOI: 10.1186/2191-219X-2-43  0.348
2012 Jansen NL, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? European Journal of Nuclear Medicine and Molecular Imaging. 39: 1021-9. PMID 22491781 DOI: 10.1007/S00259-012-2109-9  0.305
2012 Mille E, Cumming P, Rominger A, La Fougère C, Tatsch K, Wängler B, Bartenstein P, Böning G. Compensation for cranial spill-in into the cerebellum improves quantitation of striatal dopamine Dâ‚‚/₃ receptors in rats with prolonged [¹⁸F]-DMFP infusions. Synapse (New York, N.Y.). 66: 705-13. PMID 22460766 DOI: 10.1002/Syn.21558  0.446
2012 Virdee K, Cumming P, Caprioli D, Jupp B, Rominger A, Aigbirhio FI, Fryer TD, Riss PJ, Dalley JW. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders. Neuroscience and Biobehavioral Reviews. 36: 1188-216. PMID 22342372 DOI: 10.1016/J.Neubiorev.2012.01.009  0.43
2012 Cumming P, Borghammer P. Molecular imaging and the neuropathologies of Parkinson's disease. Current Topics in Behavioral Neurosciences. 11: 117-48. PMID 22034053 DOI: 10.1007/7854_2011_165  0.321
2012 Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics. Addiction Biology. 17: 490-503. PMID 22023291 DOI: 10.1111/J.1369-1600.2011.00355.X  0.406
2012 Borghammer P, Cumming P, Østergaard K, Gjedde A, Rodell A, Bailey CJ, Vafaee MS. Cerebral oxygen metabolism in patients with early Parkinson's disease. Journal of the Neurological Sciences. 313: 123-8. PMID 21975016 DOI: 10.1016/J.Jns.2011.09.010  0.322
2012 Ersche KD, Cumming P, Craig KJ, Müller U, Fineberg NA, Bullmore ET, Robbins TW. Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions? Journal of Psychopharmacology (Oxford, England). 26: 887-90. PMID 21746752 DOI: 10.1177/0269881111405363  0.307
2012 Deutschlander A, Fougere CL, Xiong GM, Bötzel K, Gründer G, Cumming P. Therapeutic Occupancy of the D2/3-Preferring Dopamine Receptor Agonist Pramipexol in Brains of Patients with Parkinson's Disease ([18F]-Fallypride PET Study) (P03.126) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.126  0.42
2012 Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral beta-amyloid in APP-swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.411  0.317
2012 Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral Aβ in APP-Swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8: 11. DOI: 10.1016/J.Jalz.2012.05.033  0.333
2011 Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G, Funke U, Sabri O, Peters D, Brust P. Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1541-9. PMID 21484373 DOI: 10.1007/S00259-011-1808-Y  0.35
2011 Cumming P. Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review. Synapse (New York, N.Y.). 65: 892-909. PMID 21308799 DOI: 10.1002/Syn.20916  0.376
2011 Palner M, Kjaerby C, Knudsen GM, Cumming P. Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat. Neurochemistry International. 58: 243-7. PMID 21163313 DOI: 10.1016/J.Neuint.2010.12.007  0.412
2011 Uebleis C, Ulbrich M, Tegtmeyer R, Schuessler F, Haserueck N, Siebermair J, Becker C, Nekolla S, Cumming P, Bartenstein P, Kääb S, Hacker M. Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 67-71. PMID 21149479 DOI: 10.2967/Jnumed.110.078709  0.334
2011 Cumming P, Caprioli D, Dalley JW. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? British Journal of Pharmacology. 163: 1586-604. PMID 20846139 DOI: 10.1111/J.1476-5381.2010.01036.X  0.363
2010 Förster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougère C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S. Functional representation of olfactory impairment in early Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 581-91. PMID 20847402 DOI: 10.3233/Jad-2010-091549  0.309
2010 Rominger A, Mille E, Zhang S, Böning G, Förster S, Nowak S, Gildehaus FJ, Wängler B, Bartenstein P, Cumming P. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1576-83. PMID 20847158 DOI: 10.2967/Jnumed.110.078451  0.377
2010 Bartmann H, Fuest C, la Fougere C, Xiong G, Just T, Schlichtiger J, Winter P, Böning G, Wängler B, Pekcec A, Soerensen J, Bartenstein P, Cumming P, Potschka H. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. Epilepsia. 51: 1780-90. PMID 20633036 DOI: 10.1111/J.1528-1167.2010.02671.X  0.359
2010 Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 951-60. PMID 20392299 DOI: 10.1017/S1461145710000374  0.41
2010 Rominger A, Mille E, Böning G, Wängler B, Josef Gildehaus F, Arszol C, Bartenstein P, Cumming P. α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse. Synapse (New York, N.Y.). 64: 654-7. PMID 20336625 DOI: 10.1002/Syn.20785  0.395
2010 la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 581-7. PMID 20237026 DOI: 10.2967/Jnumed.109.071811  0.414
2010 Gjedde A, Kumakura Y, Cumming P, Linnet J, Møller A. Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proceedings of the National Academy of Sciences of the United States of America. 107: 3870-5. PMID 20133675 DOI: 10.1073/Pnas.0912319107  0.38
2010 Minuzzi L, Cumming P. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study. Neurochemistry International. 56: 747-52. PMID 20117160 DOI: 10.1016/J.Neuint.2010.01.010  0.421
2010 Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse. Synapse (New York, N.Y.). 64: 313-22. PMID 19957365 DOI: 10.1002/Syn.20730  0.473
2010 Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, Gründer G, Bartenstein P, Cumming P. Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease. Neuroimage. 49: 2933-9. PMID 19941962 DOI: 10.1016/J.Neuroimage.2009.11.035  0.411
2010 Förster S, Teipel S, Zach C, Rominger A, Cumming P, Fougere Cl, Yakushev I, Haslbeck M, Hampel H, Bartenstein P, Bürger K. FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease. Journal of Psychiatric Research. 44: 462-9. PMID 19875130 DOI: 10.1016/J.Jpsychires.2009.09.012  0.309
2010 la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, ... Cumming P, et al. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 49: 1406-15. PMID 19796699 DOI: 10.1016/J.Neuroimage.2009.09.048  0.402
2010 Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion. Synapse (New York, N.Y.). 64: 70-82. PMID 19768811 DOI: 10.1002/Syn.20706  0.41
2010 Yakushev IY, Dupont E, Buchholz HG, Tillmanns J, Debus F, Cumming P, Heimann A, Fellgiebel A, Luhmann HJ, Landvogt C, Werhahn KJ, Schreckenberger M, Potschka H, Bartenstein P. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia. 51: 415-22. PMID 19694792 DOI: 10.1111/J.1528-1167.2009.02272.X  0.443
2010 Kumakura Y, Vernaleken I, Buchholz HG, Borghammer P, Danielsen E, Gründer G, Heinz A, Bartenstein P, Cumming P. Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiology of Aging. 31: 447-63. PMID 18541344 DOI: 10.1016/J.Neurobiolaging.2008.05.005  0.412
2009 Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 15: 635-50. PMID 19793723 DOI: 10.1177/1073858409338217  0.423
2009 Borghammer P, Cumming P, Aanerud J, Förster S, Gjedde A. Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization. Neuroimage. 47: 1514-21. PMID 19465133 DOI: 10.1016/J.Neuroimage.2009.05.040  0.3
2009 Mörtberg E, Cumming P, Wiklund L, Rubertsson S. Cerebral metabolic rate of oxygen (CMRO2) in pig brain determined by PET after resuscitation from cardiac arrest. Resuscitation. 80: 701-6. PMID 19395145 DOI: 10.1016/J.Resuscitation.2009.03.005  0.361
2009 Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, Hashemi SH, Baaré WF, Madsen J, Hasselbalch SG, Kringelbach ML, Mortensen EL, Knudsen GM. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 45: 280-5. PMID 19135154 DOI: 10.1016/J.Neuroimage.2008.12.001  0.329
2008 Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, et al. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). Journal of Clinical Psychopharmacology. 28: 608-17. PMID 19011428 DOI: 10.1097/Jcp.0B013E31818Ba2F6  0.358
2008 Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG, Smolka MN, Gründer G, Cumming P, Kumakura Y, Bartenstein P, Dolan RJ, Heinz A. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nature Neuroscience. 11: 1381-2. PMID 18978778 DOI: 10.1038/Nn.2222  0.355
2008 Vernaleken I, Cumming P, Gründer G. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective. Pharmacopsychiatry. 41: S60-9. PMID 18756422 DOI: 10.1055/S-0028-1082058  0.36
2008 Jensen SB, Di Santo R, Olsen AK, Pedersen K, Costi R, Cirilli R, Cumming P. Synthesis and cerebral uptake of 1-(1-[(11)C]methyl-1H-pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl)ethanone, a novel tracer for positron emission tomography studies of monoamine oxidase type A. Journal of Medicinal Chemistry. 51: 1617-22. PMID 18307289 DOI: 10.1021/Jm701378E  0.417
2008 Vernaleken I, Kumakura Y, Buchholz HG, Siessmeier T, Hilgers RD, Bartenstein P, Cumming P, Gründer G. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects. Neuroimage. 40: 1222-31. PMID 18262797 DOI: 10.1016/J.Neuroimage.2007.12.045  0.406
2008 Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A. Normalization in PET group comparison studies--the importance of a valid reference region. Neuroimage. 40: 529-40. PMID 18258457 DOI: 10.1016/J.Neuroimage.2007.12.057  0.324
2008 Kienast T, Siessmeier T, Wrase J, Braus DF, Smolka MN, Buchholz HG, Rapp M, Schreckenberger M, Rösch F, Cumming P, Gruender G, Mann K, Bartenstein P, Heinz A. Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1147-58. PMID 18202844 DOI: 10.1007/S00259-007-0683-Z  0.381
2008 Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 824-31. PMID 17971791 DOI: 10.1038/Sj.Jcbfm.9600571  0.375
2008 Borghammer P, Vafaee M, Ostergaard K, Rodell A, Bailey C, Cumming P. Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease. Acta Neurologica Scandinavica. 117: 317-23. PMID 17927800 DOI: 10.1111/J.1600-0404.2007.00943.X  0.354
2008 Linnet J, Møller A, Kumakura Y, Cumming P, Gjedde A. Low dopamine receptor availability in brain of highly sensation-seeking men Neuroimage. 41: T131. DOI: 10.1016/J.Neuroimage.2008.04.099  0.373
2007 Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Gründer G. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8080-7. PMID 17652599 DOI: 10.1523/Jneurosci.0805-07.2007  0.407
2007 Mörtberg E, Cumming P, Wiklund L, Wall A, Rubertsson S. A PET study of regional cerebral blood flow after experimental cardiopulmonary resuscitation. Resuscitation. 75: 98-104. PMID 17499906 DOI: 10.1016/J.Resuscitation.2007.03.020  0.344
2007 Gramsbergen JB, Cumming P. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats. Neurochemistry International. 51: 8-15. PMID 17475367 DOI: 10.1016/J.Neuint.2007.03.004  0.309
2007 Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, Hansen AK. The use of pigs in neuroscience: modeling brain disorders. Neuroscience and Biobehavioral Reviews. 31: 728-51. PMID 17445892 DOI: 10.1016/J.Neubiorev.2007.02.003  0.32
2007 Cumming P, Møller M, Benda K, Minuzzi L, Jakobsen S, Jensen SB, Pakkenberg B, Stark AK, Gramsbergen JB, Andreasen MF, Olsen AK. A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain. Synapse (New York, N.Y.). 61: 478-87. PMID 17415793 DOI: 10.1002/Syn.20377  0.4
2007 Mezzomo K, Cumming P, Minuzzi L. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. European Journal of Pharmacology. 564: 75-9. PMID 17350614 DOI: 10.1016/J.Ejphar.2007.01.087  0.365
2007 Pedersen K, Simonsen M, Østergaard SD, Munk OL, Rosa-Neto P, Olsen AK, Jensen SB, Møller A, Cumming P. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage. 35: 38-46. PMID 17223363 DOI: 10.1016/J.Neuroimage.2006.11.038  0.447
2007 Vernaleken I, Weibrich C, Siessmeier T, Buchholz HG, Rösch F, Heinz A, Cumming P, Stoeter P, Bartenstein P, Gründer G. Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age. Neuroimage. 34: 870-8. PMID 17174574 DOI: 10.1016/J.Neuroimage.2006.10.013  0.356
2007 Vernaleken I, Buchholz HG, Kumakura Y, Siessmeier T, Stoeter P, Bartenstein P, Cumming P, Gründer G. 'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation. Human Brain Mapping. 28: 931-9. PMID 17133402 DOI: 10.1002/Hbm.20325  0.37
2006 Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rösch F, Cumming P, Mann K, Bartenstein P, Heinz A. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. The European Journal of Neuroscience. 24: 305-13. PMID 16882026 DOI: 10.1111/J.1460-9568.2006.04903.X  0.366
2006 Jakobsen S, Kodahl GM, Olsen AK, Cumming P. Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand. Nuclear Medicine and Biology. 33: 593-7. PMID 16843833 DOI: 10.1016/J.Nucmedbio.2006.04.006  0.367
2006 Smith DF, Dyve S, Minuzzi L, Jakobsen S, Munk OL, Marthi K, Cumming P. Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse (New York, N.Y.). 59: 463-71. PMID 16565964 DOI: 10.1002/Syn.20262  0.405
2006 Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, Keiding S. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. European Journal of Nuclear Medicine and Molecular Imaging. 33: 810-6. PMID 16550382 DOI: 10.1007/S00259-005-0052-8  0.373
2006 Cumming P, Pedersen MD, Minuzzi L, Mezzomo K, Danielsen EH, Iversen P, Aagaard D, Keiding S, Munk OL, Finsen B. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography. Synapse (New York, N.Y.). 59: 418-26. PMID 16485266 DOI: 10.1002/Syn.20257  0.425
2006 Jensen SB, Olsen AK, Pedersen K, Cumming P. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride. Synapse (New York, N.Y.). 59: 427-34. PMID 16485265 DOI: 10.1002/Syn.20258  0.399
2006 Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, Müller MJ, Bartenstein P, Gründer G. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage. 30: 1332-9. PMID 16439159 DOI: 10.1016/J.Neuroimage.2005.11.014  0.413
2006 Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo. Synapse (New York, N.Y.). 59: 211-9. PMID 16385509 DOI: 10.1002/Syn.20234  0.452
2006 Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage. 30: 26-35. PMID 16378735 DOI: 10.1016/J.Neuroimage.2005.09.044  0.396
2006 Smith DF, Marthi K, Munk OL, Cumming P, Hansen SB, Jakobsen S. PET neuroimaging of [11C]mirtazapine enantiomers in pigs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 350-7. PMID 16361085 DOI: 10.1016/J.Euroneuro.2005.10.008  0.372
2006 Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 358-70. PMID 16079784 DOI: 10.1038/Sj.Jcbfm.9600202  0.378
2006 Peterson E, Gjedde A, Rodell A, Cumming P, Moller A, Linnet J. High sensation seeking men have increased dopamine binding in the right putamen during gambling, determined from raclopride binding potentials Neuroimage. 31: T168. DOI: 10.1016/J.Neuroimage.2006.04.151  0.337
2006 Smith DF, Marthi K, Jakobsen S, Bender D, Hansen S, Smith B, Hermansen F, Rosenberg R, Cumming P. PET neuroimaging of racemic [11C]mirtazapine and enantiomers: Pharmacokinetic models and alpha-noradrenergic binding sites Neuroimage. 31: T125. DOI: 10.1016/J.Neuroimage.2006.04.110  0.321
2006 Jakobsen S, Pedersen K, Smith DF, Jensen SB, Olsen AK, Cumming P. Detection of alphe-2 adrenergic receptora in brain of living pig with [11C]yohimbine Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.109  0.311
2006 Pedersen K, Gjedde A, Olsen Å, Jakobsen S, Cumming P, Jensen S. Binding of the hallucinogen [11C]MeO-DMT in the brain of living pigs Neuroimage. 31: T53. DOI: 10.1016/J.Neuroimage.2006.04.044  0.337
2005 Borghammer P, Kumakura Y, Cumming P. Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease. Archives of Neurology. 62: 1480; author reply 1. PMID 16157762 DOI: 10.1001/Archneur.62.9.1480-A  0.334
2005 Heinz A, Siessmeier T, Wrase J, Buchholz HG, Gründer G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. The American Journal of Psychiatry. 162: 1515-20. PMID 16055774 DOI: 10.1176/Appi.Ajp.162.8.1515  0.353
2005 Lind NM, Gjedde A, Moustgaard A, Olsen AK, Jensen SB, Jakobsen S, Arnfred SM, Hansen AK, Hemmingsen RP, Cumming P. Behavioral response to novelty correlates with dopamine receptor availability in striatum of Göttingen minipigs. Behavioural Brain Research. 164: 172-7. PMID 16043240 DOI: 10.1016/J.Bbr.2005.06.008  0.4
2005 Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rösch F, Schreckenberger M, Wong DF, Cumming P, Gründer G, Bartenstein P. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 964-72. PMID 15937307  0.313
2005 Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. International Journal of Radiation Oncology, Biology, Physics. 62: 854-61. PMID 15936570 DOI: 10.1016/J.Ijrobp.2005.02.044  0.323
2005 Andersen F, Watanabe H, Bjarkam C, Danielsen EH, Cumming P. Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning. Brain Research Bulletin. 66: 17-29. PMID 15925140 DOI: 10.1016/J.Brainresbull.2005.02.033  0.35
2005 Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage. 25: 868-76. PMID 15808987 DOI: 10.1016/J.Neuroimage.2004.11.031  0.342
2005 Minuzzi L, Nomikos GG, Wade MR, Jensen SB, Olsen AK, Cumming P. Interaction between LSD and dopamine D2/3 binding sites in pig brain. Synapse (New York, N.Y.). 56: 198-204. PMID 15803496 DOI: 10.1002/Syn.20141  0.45
2005 Gjedde A, Wong DF, Rosa-Neto P, Cumming P. Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress. International Review of Neurobiology. 63: 1-20. PMID 15797463 DOI: 10.1016/S0074-7742(05)63001-2  0.354
2005 Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 807-19. PMID 15729292 DOI: 10.1038/Sj.Jcbfm.9600079  0.415
2005 Lind NM, Olsen AK, Moustgaard A, Jensen SB, Jakobsen S, Hansen AK, Arnfred SM, Hemmingsen RP, Gjedde A, Cumming P. Mapping the amphetamine-evoked dopamine release in the brain of the Göttingen minipig. Brain Research Bulletin. 65: 1-9. PMID 15680539 DOI: 10.1016/J.Brainresbull.2004.08.007  0.398
2005 Jelsing J, Olsen AK, Cumming P, Gjedde A, Hansen AK, Arnfred S, Hemmingsen R, Pakkenberg B. A volumetric screening procedure for the Göttingen minipig brain. Experimental Brain Research. 162: 428-35. PMID 15668795 DOI: 10.1007/S00221-004-2026-7  0.305
2005 Vernaleken I, Kumakura Y, Buchholz H, Siessmeier T, Bartenstein P, Cumming P, Gründer G. Prefrontal cognitive performance of healthy subjects positively correlates with 18F-FDOPA uptake in positron emission tomography Pharmacopsychiatry. 38. DOI: 10.1055/S-2005-918861  0.329
2004 Kumakura Y, Danielsen EH, Reilhac A, Gjedde A, Cumming P. Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurologica Scandinavica. 110: 188-95. PMID 15285777 DOI: 10.1111/J.1600-0404.2004.00299.X  0.43
2004 Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain. Synapse (New York, N.Y.). 53: 222-33. PMID 15266554 DOI: 10.1002/Syn.20053  0.448
2004 Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia. Synapse (New York, N.Y.). 53: 214-21. PMID 15266553 DOI: 10.1002/Syn.20052  0.389
2004 Bender D, Olsen AK, Marthi MK, Smith DF, Cumming P. PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brain. Nuclear Medicine and Biology. 31: 699-704. PMID 15246360 DOI: 10.1016/J.Nucmedbio.2004.03.005  0.377
2004 Rosa-Neto P, Doudet DJ, Cumming P. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage. 22: 1076-83. PMID 15219579 DOI: 10.1016/J.Neuroimage.2004.03.004  0.434
2004 Vafaee MS, ØStergaard K, Sunde N, Gjedde A, Dupont E, Cumming P. Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation. Neuroimage. 22: 966-74. PMID 15193628 DOI: 10.1016/J.Neuroimage.2004.02.019  0.336
2004 Lou HC, Rosa P, Pryds O, Karrebaek H, Lunding J, Cumming P, Gjedde A. ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow. Developmental Medicine and Child Neurology. 46: 179-83. PMID 14995087 DOI: 10.1017/S0012162204000313  0.343
2003 Kretzschmar M, Brust P, Zessin J, Cumming P, Bergmann R, Johannsen B. Autoradiographic imaging of the serotonin transporter in the brain of rats and pigs using S-([18F]fluoromethyl)-(+)-McN5652. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 387-97. PMID 12957338 DOI: 10.1016/S0924-977X(03)00039-7  0.419
2003 Cumming P, Rosa-Neto P, Watanabe H, Smith D, Bender D, Clarke PB, Gjedde A. Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain. Neuroimage. 19: 1127-36. PMID 12880838 DOI: 10.1016/S1053-8119(03)00079-X  0.405
2003 Cumming P, Gillings NM, Jensen SB, Bjarkam C, Gjedde A. Kinetics of the uptake and distribution of the dopamine D(2,3) agonist (R)-N-[1-(11)C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs. Nuclear Medicine and Biology. 30: 547-53. PMID 12831994 DOI: 10.1016/S0969-8051(02)00448-1  0.461
2003 Jensen SB, Smith DF, Bender D, Jakobsen S, Peters D, Nielsen EØ, Olsen GM, Scheel-Krüger J, Wilson A, Cumming P. [11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain. Synapse (New York, N.Y.). 49: 170-7. PMID 12774301 DOI: 10.1002/Syn.10222  0.399
2003 Gründer G, Vernaleken I, Müller MJ, Davids E, Heydari N, Buchholz HG, Bartenstein P, Munk OL, Stoeter P, Wong DF, Gjedde A, Cumming P. Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 787-94. PMID 12655326 DOI: 10.1038/Sj.Npp.1300103  0.418
2003 Audrain H, Bender D, Scheel-Krüger J, Nielsen E, Olsen GM, Peters D, Cumming P. Synthesis of the serotonin transporter ligand (±)-10-methyl 3-[6-nitro-(2-quinolinyl)]-3,10-diazabicyclo-[4.3.1]-decane ([ 11C-methyl]NS 2495) and first in vivo results Journal of Labelled Compounds and Radiopharmaceuticals. 46: 873-882. DOI: 10.1002/Jlcr.726  0.384
2002 Dall AM, Danielsen EH, Sørensen JC, Andersen F, Møller A, Zimmer J, Gjedde AH, Cumming P. Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation. 11: 733-46. PMID 12588105 DOI: 10.3727/000000002783985314  0.326
2002 Pradhan AA, Cumming P, Clarke PB. [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Brain Research. 954: 227-36. PMID 12414106 DOI: 10.1016/S0006-8993(02)03340-1  0.358
2002 Cumming P, Wong DF, Dannals RF, Gillings N, Hilton J, Scheffel U, Gjedde A. The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors. Annals of the New York Academy of Sciences. 965: 440-50. PMID 12105119 DOI: 10.1111/J.1749-6632.2002.Tb04185.X  0.402
2002 Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Annals of the New York Academy of Sciences. 965: 434-9. PMID 12105118 DOI: 10.1111/J.1749-6632.2002.Tb04184.X  0.377
2002 Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 596-604. PMID 11973432 DOI: 10.1097/00004647-200205000-00011  0.395
2001 Watanabe H, Andersen F, Simonsen CZ, Evans SM, Gjedde A, Cumming P. MR-based statistical atlas of the Göttingen minipig brain. Neuroimage. 14: 1089-96. PMID 11697940 DOI: 10.1006/Nimg.2001.0910  0.376
2001 Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse (New York, N.Y.). 42: 48-53. PMID 11668590 DOI: 10.1002/Syn.1098  0.363
2001 Danielsen EH, Smith DF, Andersen F, Gee AD, Bender D, Hansen SB, Hermansen F, Østergaard L, Cumming P, Gjedde A. FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation. Journal of Neuroscience Methods. 111: 157-68. PMID 11595282 DOI: 10.1016/S0165-0270(01)00453-8  0.384
2001 Danielsen EH, Smith D, Hermansen F, Gjedde A, Cumming P. Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo. Synapse (New York, N.Y.). 41: 172-5. PMID 11400183 DOI: 10.1002/Syn.1071  0.422
2001 Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during PET with FDOPA. Synapse (New York, N.Y.). 41: 212-8. PMID 11391782 DOI: 10.1002/Syn.1077  0.369
2001 Cumming P, Danielsen EH, Vafaee M, Falborg L, Steffensen E, Sørensen JC, Gillings N, Bender D, Marthi K, Andersen F, Munk O, Smith D, Møller A, Gjedde A. Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts. Acta Neurologica Scandinavica. 103: 309-15. PMID 11328207 DOI: 10.1034/J.1600-0404.2001.103005309.X  0.417
2001 Smith DF, Bender D, Marthi K, Cumming P, Hansen SB, Peters D, Nielsen EO, Scheel-Krüger J, Gjedde A. Synthesis and evaluation of racemic [(11)C]NS2456 and enantiomers as selective serotonin reuptake radiotracers for PET. Nuclear Medicine and Biology. 28: 265-70. PMID 11323236 DOI: 10.1016/S0969-8051(00)00175-X  0.423
2001 Gillings NM, Bender D, Falborg L, Marthi K, Munk OL, Cumming P. Kinetics of the metabolism of four PET radioligands in living minipigs. Nuclear Medicine and Biology. 28: 97-104. PMID 11182570 DOI: 10.1016/S0969-8051(00)00187-6  0.311
2001 Cumming P, Kretzschmar M, Brust P, Smith DF. Quantitative radioluminography of serotonin uptake sites in the porcine brain. Synapse (New York, N.Y.). 39: 351-5. PMID 11169786 DOI: 10.1002/1098-2396(20010315)39:4<351::Aid-Syn1019>3.0.Co;2-M  0.39
2001 Smith DF, Bender D, Marthi K, Cumming P, Hansen SB, Peters D, Nielsen EØ, Scheel-Krüger J, Gjedde A. Synthesis and in vivo evaluation (PIG) of the selective seretonin reuptake inhibitor [11C]NS 2456 Journal of Labelled Compounds and Radiopharmaceuticals. 44: S198-S200. DOI: 10.1002/Jlcr.2580440169  0.394
2000 Ishizu K, Smith DF, Bender D, Danielsen E, Hansen SB, Wong DF, Cumming P, Gjedde A. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release. Synapse (New York, N.Y.). 38: 87-101. PMID 10941144 DOI: 10.1002/1098-2396(200010)38:1<87::Aid-Syn10>3.0.Co;2-C  0.398
2000 Rousset OG, Deep P, Kuwabara H, Evans AC, Gjedde AH, Cumming P. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Synapse (New York, N.Y.). 37: 81-9. PMID 10881028 DOI: 10.1002/1098-2396(200008)37:2<81::Aid-Syn1>3.0.Co;2-#  0.429
2000 Danielsen EH, Cumming P, Andersen F, Bender D, Brevig T, Falborg L, Gee A, Gillings NM, Hansen SB, Hermansen F, Johansen J, Johansen TE, Dahl-Jørgensen A, Jørgensen HA, Meyer M, et al. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers. Cell Transplantation. 9: 247-59. PMID 10811397 DOI: 10.1177/096368970000900210  0.3
2000 Marenco T, Bernstein S, Cumming P, Clarke PB. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats. British Journal of Pharmacology. 129: 147-55. PMID 10694214 DOI: 10.1038/Sj.Bjp.0703005  0.309
1999 Deep P, Dagher A, Sadikot A, Gjedde A, Cumming P. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Synapse (New York, N.Y.). 34: 313-8. PMID 10529725 DOI: 10.1002/(Sici)1098-2396(19991215)34:4<313::Aid-Syn7>3.0.Co;2-1  0.418
1999 Cumming P, Hermansen F, Gjedde A. Cerebral dopamine concentrations during levodopa treatment. Neurology. 53: 1374-5. PMID 10522916 DOI: 10.1212/Wnl.53.6.1374  0.313
1999 Cumming P, Yokoi F, Chen A, Deep P, Dagher A, Reutens D, Kapczinski F, Wong DF, Gjedde A. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse (New York, N.Y.). 34: 124-34. PMID 10502311 DOI: 10.1002/(Sici)1098-2396(199911)34:2<124::Aid-Syn5>3.0.Co;2-O  0.381
1999 Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography. Synapse (New York, N.Y.). 33: 247-58. PMID 10421705 DOI: 10.1002/(Sici)1098-2396(19990915)33:4<247::Aid-Syn1>3.0.Co;2-6  0.402
1998 Léger G, Gjedde A, Kuwabara H, Guttman M, Cumming P. Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness. Synapse (New York, N.Y.). 30: 351-61. PMID 9826227 DOI: 10.1002/(Sici)1098-2396(199812)30:4<351::Aid-Syn2>3.0.Co;2-2  0.436
1998 Cumming P, Ase A, Kuwabara H, Gjedde A. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 491-9. PMID 9591841 DOI: 10.1097/00004647-199805000-00004  0.417
1998 Reith J, Cumming P, Gjedde A. Enhanced [3H]DOPA and [3H]dopamine turnover in striatum and frontal cortex in vivo linked to glutamate receptor antagonism. Journal of Neurochemistry. 70: 1979-85. PMID 9572282 DOI: 10.1046/J.1471-4159.1998.70051979.X  0.395
1998 Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse (New York, N.Y.). 29: 37-61. PMID 9552174 DOI: 10.1002/(Sici)1098-2396(199805)29:1<37::Aid-Syn4>3.0.Co;2-C  0.415
1997 Cumming P, Deep P, Rousset O, Evans A, Gjedde A. On the rate of decarboxylation of dopa to dopamine in living mammalian brain. Annals of the New York Academy of Sciences. 835: 274-308. PMID 9616781 DOI: 10.1111/J.1749-6632.1997.Tb48637.X  0.379
1997 Deep P, Kuwabara H, Gjedde A, Cumming P. The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms. Journal of Neuroscience Methods. 78: 157-68. PMID 9497012 DOI: 10.1016/S0165-0270(97)00147-7  0.381
1997 Cumming P, Ase A, Laliberté C, Kuwabara H, Gjedde A. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 1254-60. PMID 9390657 DOI: 10.1097/00004647-199711000-00014  0.408
1997 Deep P, Gjedde A, Cumming P. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo. Journal of Neuroscience Methods. 76: 157-65. PMID 9350967 DOI: 10.1016/S0165-0270(97)00094-0  0.327
1997 Cumming P, Ljubic-Thibal V, Laliberté C, Diksic M. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat. Brain Research. 747: 60-9. PMID 9042528 DOI: 10.1016/S0006-8993(96)01227-9  0.342
1997 Benkelfat C, Nishizawa S, Kuwabara H, Lal S, Chouinard G, Cumming P, Labelle A, Joober R, Bruce K, Dikksic M, Gjedde A. Brain dopa-decarboxylase (DDC) activity in unmedicated schizophrenic patients Schizophrenia Research. 24: 176. DOI: 10.1016/S0920-9964(97)82505-4  0.324
1997 Reith J, Cumming P, Gjedde A. 2-30-26 Chronic glutamate receptor antagonism linked to markedly enhanced activities of enzymes of dopamine synthesis and breakdown in vivo Journal of the Neurological Sciences. 150: S114. DOI: 10.1016/S0022-510X(97)85404-4  0.308
1995 Cumming P, Kuwabara H, Ase A, Gjedde A. Regulation of DOPA decarboxylase activity in brain of living rat. Journal of Neurochemistry. 65: 1381-90. PMID 7643116 DOI: 10.1046/J.1471-4159.1995.65031381.X  0.385
1995 Cumming P, Ase A, Diksic M, Harrison J, Jolly D, Kuwabara H, Laliberté C, Gjedde A. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat. Biochemical Pharmacology. 50: 943-6. PMID 7575677 DOI: 10.1016/0006-2952(95)00216-M  0.392
1994 Cumming P, Gjedde A. Subclasses of histamine H3 antagonist binding sites in rat brain. Brain Research. 641: 203-7. PMID 8012822 DOI: 10.1016/0006-8993(94)90147-3  0.339
1994 Cumming P, Gjedde A, Vincent S. Histamine H3 binding sites in rat brain: localization in the nucleus of the solitary tract. Brain Research. 641: 198-202. PMID 8012821 DOI: 10.1016/0006-8993(94)90146-5  0.586
1994 Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, Bachneff S, Cumming P, Diksic M, Dyve SE, Etienne P, Evans AC, Lal S, Shevell M, Savard G, et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proceedings of the National Academy of Sciences of the United States of America. 91: 11651-4. PMID 7972118 DOI: 10.1073/Pnas.91.24.11651  0.364
1994 Cumming P, Kuwabara H, Gjedde A. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat. Journal of Neurochemistry. 63: 1675-82. PMID 7931323 DOI: 10.1046/J.1471-4159.1994.63051675.X  0.327
1994 Cumming P, Venkatachalam TK, Rajagopal S, Diksic M, Gjedde A. Brain uptake of alpha-[14C]methyl-para-tyrosine in the rat. Synapse (New York, N.Y.). 17: 125-8. PMID 7916491 DOI: 10.1002/Syn.890170208  0.359
1994 Cumming P, Laliberté C, Gjedde A. Distribution of histamine H3 binding in forebrain of mouse and guinea pig. Brain Research. 664: 276-9. PMID 7895042 DOI: 10.1016/0006-8993(94)91985-2  0.333
1993 Hoshi H, Kuwabara H, Léger G, Cumming P, Guttman M, Gjedde A. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 57-69. PMID 8417011 DOI: 10.1038/Jcbfm.1993.8  0.319
1993 Kuwabara H, Cumming P, Reith J, Léger G, Diksic M, Evans AC, Gjedde A. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 43-56. PMID 8417009 DOI: 10.1038/Jcbfm.1993.7  0.422
1993 Cumming P, Vincent SR. Altered histamine H3 binding in rat forebrain after reserpine treatment. Brain Research. 602: 53-6. PMID 8383572 DOI: 10.1016/0006-8993(93)90240-N  0.589
1993 Gjedde A, Léger GC, Cumming P, Yasuhara Y, Evans AC, Guttman M, Kuwabara H. Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. Journal of Neurochemistry. 61: 1538-41. PMID 8377003 DOI: 10.1111/J.1471-4159.1993.Tb13651.X  0.351
1993 Cumming P, Léger GC, Kuwabara H, Gjedde A. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 668-75. PMID 8314919 DOI: 10.1038/Jcbfm.1993.85  0.33
1993 Cumming P, Gjedde A. Kinetics of the uptake of [3H]paroxetine in the rat brain. Synapse (New York, N.Y.). 15: 124-9. PMID 8259523 DOI: 10.1002/Syn.890150204  0.387
1992 Cumming P, Vincent SR. Inhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by beta-carbolines. Biochemical Pharmacology. 44: 989-92. PMID 1530666 DOI: 10.1016/0006-2952(92)90133-4  0.557
1992 Cumming P, Brown E, Damsma G, Fibiger H. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. Journal of Neurochemistry. 59: 1905-14. PMID 1383428 DOI: 10.1111/J.1471-4159.1992.Tb11026.X  0.344
1991 Cumming P, Damsma G, Fibiger HC, Vincent SR. Characterization of extracellular histamine in the striatum and bed nucleus of the stria terminalis of the rat: an in vivo microdialysis study. Journal of Neurochemistry. 56: 1797-803. PMID 1707442 DOI: 10.1111/J.1471-4159.1991.Tb02083.X  0.587
1991 Cumming P, Shaw C, Vincent SR. High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain. Synapse (New York, N.Y.). 8: 144-51. PMID 1652795 DOI: 10.1002/Syn.890080208  0.586
1990 Cumming P, Reiner PB, Vincent SR. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Biochemical Pharmacology. 40: 1345-50. PMID 2403387 DOI: 10.1016/0006-2952(90)90402-7  0.595
1990 Cumming P, Damsma G, Fibiger HC, Vincent SR. Determination of histamine in cerebral dialysates from the rat European Journal of Pharmacology. 183: 442. DOI: 10.1016/0014-2999(90)93329-O  0.542
1989 Cumming P, Jakubovic A, Vincent SR. Cerebral histamine levels are unaffected by MPTP administration in the mouse. European Journal of Pharmacology. 166: 299-301. PMID 2792195 DOI: 10.1016/0014-2999(89)90071-X  0.599
1988 Cumming P, Häusser M, Martin WR, Grierson J, Adam MJ, Ruth TJ, McGeer EG. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat. Biochemical Pharmacology. 37: 247-50. PMID 3124856 DOI: 10.1016/0006-2952(88)90725-3  0.345
1987 Cumming P, Boyes BE, Martin WR, Adam M, Ruth TJ, McGeer EG. Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521. Biochemical Pharmacology. 36: 2527-31. PMID 3111485 DOI: 10.1016/0006-2952(87)90526-0  0.375
1987 Cumming P, Kamo H, McGeer EG, McGeer PL. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra. Neuropharmacology. 26: 1795-7. PMID 2893988 DOI: 10.1016/0028-3908(87)90136-5  0.348
1987 Radke JM, Cumming P, Vincent SR. Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse. European Journal of Pharmacology. 134: 105-8. PMID 2435563 DOI: 10.1016/0014-2999(87)90137-3  0.565
1986 Boyes BE, Cumming P, Martin WR, McGeer EG. Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. Life Sciences. 39: 2243-52. PMID 3097437 DOI: 10.1016/0024-3205(86)90403-0  0.328
1986 Cumming P, Von Krosigk M, Reiner PB, McGeer EG, Vincent SR. Absence of adrenaline neurons in the guinea pig brain: a combined immunohistochemical and high-performance liquid chromatography study. Neuroscience Letters. 63: 125-30. PMID 2869455 DOI: 10.1016/0304-3940(86)90048-0  0.57
Low-probability matches (unlikely to be authored by this person)
2022 Gündel D, Toussaint M, Lai TH, Deuther-Conrad W, Cumming P, Schröder S, Teodoro R, Moldovan RP, Pan-Montojo F, Sattler B, Kopka K, Sabri O, Brust P. Quantitation of the A Adenosine Receptor Density in the Striatum of Mice and Pigs with [F]FLUDA by Positron Emission Tomography. Pharmaceuticals (Basel, Switzerland). 15. PMID 35631343 DOI: 10.3390/ph15050516  0.298
2023 Thomsen MB, Landau AM, Bender D, Cumming P. Autoradiographic characterization of [ F]PSMA-1007 binding in rat brain. Synapse (New York, N.Y.). PMID 37400743 DOI: 10.1002/syn.22280  0.296
2004 Gründer G, Vernaleken I, Siessmeier T, Buchholz H, Heinz A, Gjedde A, Cumming P, Bartenstein P. Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography Pharmacopsychiatry. 36. DOI: 10.1055/S-2003-825348  0.296
2021 Cumming P, Abi-Dargham A, Gründer G. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder. Behavioural Brain Research. 398: 113004. PMID 33197459 DOI: 10.1016/j.bbr.2020.113004  0.296
2009 Borghammer P, Cumming P, Aanerud J, Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Neuroimage. 45: 249-57. PMID 18718541 DOI: 10.1016/J.Neuroimage.2008.07.042  0.295
2001 Andersen F, Rodell AB, Danielsen EH, Gjedde A, Cumming P. Automatic registration of 3D-MR volumetric pig brain data into stereotactic standard coordinates (pig space) Neuroimage. 13: 1295. DOI: 10.1016/S1053-8119(01)92609-6  0.295
2010 Saam T, Rominger A, Wolpers S, Rist C, Greif M, Cumming P, Becker A, Foerster S, Reiser M, Bartenstein P, Hacker M, Nikolaou K. Assoziation entzündlicher Veränderungen der linken Koronararterie mit kardiovaskulären Risikofaktoren, atherosklerotischer Plaquelast und dem Volumen des perikardialen Fettgewebes: Eine PET/CT-Studie RöFo - Fortschritte Auf Dem Gebiet Der RöNtgenstrahlen Und Der Bildgebenden Verfahren. 182. DOI: 10.1055/S-0030-1252542  0.294
2015 Rominger A, Cumming P, Brendel M, Xiong G, Zach C, Karch S, Tatsch K, Bartenstein P, la Fougère C, Koch W, Pogarell O. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 873-81. PMID 25819144 DOI: 10.1016/J.Euroneuro.2014.12.010  0.293
2011 Yakushev I, Schreckenberger M, Müller MJ, Schermuly I, Cumming P, Stoeter P, Gerhard A, Fellgiebel A. Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study. European Journal of Nuclear Medicine and Molecular Imaging. 38: 2219-27. PMID 21792570 DOI: 10.1007/S00259-011-1882-1  0.293
2012 Graute V, Jansen N, Ubleis C, Seitz M, Hartenbach M, Scherr MK, Thieme S, Cumming P, Klanke K, Tiling R, Bartenstein P, Hacker M. Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging. 39: 271-82. PMID 22086143 DOI: 10.1007/S00259-011-1970-2  0.292
2012 Holland JP, Cumming P, Vasdev N. PET of signal transduction pathways in cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1333-6. PMID 22879078 DOI: 10.2967/Jnumed.112.105387  0.288
1999 Cumming P, Reith J, Gjedde A. Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA) Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 395-8. PMID 10088142 DOI: 10.1016/S0893-133X(98)00096-7  0.288
2007 Watanabe H, Sakoh M, Andersen F, Rodell A, Sørensen JC, Østergaard L, Mouridsen K, Cumming P. Statistical mapping of effects of middle cerebral artery occlusion (MCAO) on blood flow and oxygen consumption in porcine brain. Journal of Neuroscience Methods. 160: 109-15. PMID 17129609 DOI: 10.1016/J.Jneumeth.2006.08.016  0.287
2021 Casado-Sainz A, Gudmundsen F, Baerentzen SL, Lange D, Ringsted A, Martinez-Tejada I, Medina S, Lee H, Svarer C, Keller SH, Schain M, Kjaerby C, Fisher PM, Cumming P, Palner M. Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34725486 DOI: 10.1038/s41386-021-01207-y  0.286
2020 Prenosil GA, Weitzel T, Fürstner M, Hentschel M, Krause T, Cumming P, Rominger A, Klaeser B. Towards guidelines to harmonize textural features in PET: Haralick textural features vary with image noise, but exposure-invariant domains enable comparable PET radiomics. Plos One. 15: e0229560. PMID 32176698 DOI: 10.1371/Journal.Pone.0229560  0.285
2010 Rominger A, Saam T, Vogl E, Ubleis C, la Fougère C, Förster S, Haug A, Cumming P, Reiser MF, Nikolaou K, Bartenstein P, Hacker M. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 193-7. PMID 20080898 DOI: 10.2967/Jnumed.109.070672  0.285
2010 Saam T, Rominger A, Wolpers S, Nikolaou K, Rist C, Greif M, Cumming P, Becker A, Foerster S, Reiser MF, Bartenstein P, Hacker M. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1203-12. PMID 20300933 DOI: 10.1007/S00259-010-1432-2  0.284
2006 Pedersen MD, Minuzzi L, Wirenfeldt M, Meldgaard M, Slidsborg C, Cumming P, Finsen B. Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain. The European Journal of Neuroscience. 24: 991-1000. PMID 16930426 DOI: 10.1111/J.1460-9568.2006.04975.X  0.283
1999 Borbely K, Brooks RA, Wong DF, Burns RS, Cumming P, Gjedde A, Di Chiro G. NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy. Acta Neurologica Scandinavica. 100: 42-52. PMID 10416511 DOI: 10.1111/j.1600-0404.1999.tb00722.x  0.281
2012 Kalbitzer J, Deserno L, Schlagenhauf F, Beck A, Mell T, Bahr G, Buchholz HG, Plotkin M, Buchert R, Kumakura Y, Cumming P, Heinz A, Rapp MA. Decline in prefrontal catecholamine synthesis explains age-related changes in cognitive speed beyond regional grey matter atrophy. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1462-6. PMID 22710957 DOI: 10.1007/S00259-012-2162-4  0.28
2010 Haug AR, Auernhammer CJ, Wängler B, Schmidt GP, Uebleis C, Göke B, Cumming P, Bartenstein P, Tiling R, Hacker M. 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1349-56. PMID 20720050 DOI: 10.2967/Jnumed.110.075002  0.276
2020 Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G, von Ungern-Sternberg B, Unterrainer M, Albert NL, Zwergal A, Levin J, ... ... Cumming P, et al. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of Neuroinflammation. 17: 208. PMID 32660586 DOI: 10.1186/S12974-020-01883-5  0.273
2010 Wollenweber T, Zach C, Rischpler C, Fischer R, Nowak S, Nekolla SG, Gröbner M, Ubleis C, Assmann G, Müller-Höcker J, La Fougére C, Böning G, Cumming P, Franz WM, Hacker M. Myocardial perfusion imaging is feasible for infarct size quantification in mice using a clinical single-photon emission computed tomography system equipped with pinhole collimators. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 427-34. PMID 19937392 DOI: 10.1007/S11307-009-0281-5  0.27
2021 Sala A, Lizarraga A, Ripp I, Cumming P, Yakushev I. Static versus Functional PET: Making Sense of Metabolic Connectivity. Cerebral Cortex (New York, N.Y. : 1991). PMID 34411237 DOI: 10.1093/cercor/bhab271  0.27
2019 Mohamed AZ, Cumming P, Götz J, Nasrallah F. Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30617964 DOI: 10.1007/S00259-018-4241-7  0.27
2023 Egger K, Gudmundsen F, Jessen NS, Baun C, Poetzsch SN, Shalgunov V, Herth MM, Quednow BB, Martin-Soelch C, Dornbierer D, Scheidegger M, Cumming P, Palner M. A pilot study of cerebral metabolism and serotonin 5-HT receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. Frontiers in Pharmacology. 14: 1140656. PMID 37841918 DOI: 10.3389/fphar.2023.1140656  0.268
2021 Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules (Basel, Switzerland). 26. PMID 33922330 DOI: 10.3390/molecules26092451  0.266
2010 Borghammer P, Østergaard K, Cumming P, Gjedde A, Rodell A, Hall N, Chakravarty MM. A deformation-based morphometry study of patients with early-stage Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 314-20. PMID 19912319 DOI: 10.1111/J.1468-1331.2009.02807.X  0.265
2003 Rosa-Neto P, Olsen AK, Jensen SB, Munk OL, Watanabe H, Gjedde A, Cumming P. P.6.065 MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding potentials European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)92363-7  0.264
2019 Mohamed AZ, Cumming P, Srour H, Gunasena T, Uchida A, Haller CN, Nasrallah F. Corrigendum to 'Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury' NeuroImage: CLINICAL. 19 (2018) 716-726. Neuroimage. Clinical. 101829. PMID 31040066 DOI: 10.1016/J.Nicl.2019.101829  0.262
2000 Danielsen E, Smith D, Hermansen F, Gjedde A, Cumming P. Stimulation of DOPA decarboxylase in porcine brain with acute neuroleptics: An [ 18F]fluorodopa/PET study Neuroimage. 11: S39.  0.262
2011 Gildehaus FJ, Haasters F, Drosse I, Wagner E, Zach C, Mutschler W, Cumming P, Bartenstein P, Schieker M. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1204-14. PMID 21080231 DOI: 10.1007/S11307-010-0439-1  0.261
2019 Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. In response to: The validity of F-GE180 as a TSPO imaging agent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30826897 DOI: 10.1007/S00259-019-04294-8  0.261
2019 Mohamed AZ, Cumming P, Nasrallah FA. Response to the letter concerning the publication: Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury. Mohamed AZ, et al. NeuroImage Clinical 2018 June 5;19:716-726. Neuroimage. Clinical. 23: 101867. PMID 31146117 DOI: 10.1016/J.Nicl.2019.101867  0.258
2018 Mohamed AZ, Cumming P, Srour H, Gunasena T, Uchida A, Haller CN, Nasrallah F. Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury. Neuroimage. Clinical. 19: 716-726. PMID 30009128 DOI: 10.1016/J.Nicl.2018.05.016  0.257
2011 Haug AR, Rominger A, Mustafa M, Auernhammer C, Göke B, Schmidt GP, Wängler B, Cumming P, Bartenstein P, Hacker M. Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1679-83. PMID 21976529 DOI: 10.2967/Jnumed.111.089276  0.255
2013 Holland JP, Cumming P, Vasdev N. PET radiopharmaceuticals for probing enzymes in the brain. American Journal of Nuclear Medicine and Molecular Imaging. 3: 194-216. PMID 23638333  0.253
2011 Koller G, Rominger A, La Fougère C, Cumming P, Bartenstein P, Soyka M, Pogarell O. Striatal and extrastriatal dopamine D2 receptor availability as assessed by [18F]fallypride and PET in patients with alcohol use disorder Pharmacopsychiatry. 44. DOI: 10.1055/S-0031-1292507  0.253
2010 Koller G, La Fougere C, Rominger A, Holdtschmidt-Täschner B, Soyka M, Cumming P, Bartenstein P, Pogarell O. PW01-230 - [18F]fallypride pet measurement of striatal and extrastriatal dopamine D2/3 receptor availability in patients with alcohol use disorder European Psychiatry. 25: 1658. DOI: 10.1016/S0924-9338(10)71637-0  0.252
2011 Koller G, Rominger A, La Fougere C, Soyka M, Cumming P, Bartenstein P, Pogarell O. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in patients with alcohol use disorder Suchttherapie. 12. DOI: 10.1055/s-0031-1284660  0.252
2010 Förster S, Rieber J, Ubleis C, Weiss M, Bartenstein P, Cumming P, Klauss V, Hacker M. Tc-99m sestamibi single photon emission computed tomography for guiding percutaneous coronary intervention in patients with multivessel disease: a comparison with quantitative coronary angiography and fractional flow reserve. The International Journal of Cardiovascular Imaging. 26: 203-13. PMID 19760091 DOI: 10.1007/S10554-009-9510-X  0.252
2023 Bach P, de Timary P, Gründer G, Cumming P. Molecular Imaging Studies of Alcohol Use Disorder. Current Topics in Behavioral Neurosciences. PMID 36639552 DOI: 10.1007/7854_2022_414  0.249
2012 Uebleis C, Groebner M, von Ziegler F, Becker A, Rischpler C, Tegtmeyer R, Becker C, Lehner S, Haug AR, Cumming P, Bartenstein P, Franz WM, Hacker M. Combined anatomical and functional imaging using coronary CT angiography and myocardial perfusion SPECT in symptomatic adults with abnormal origin of a coronary artery. The International Journal of Cardiovascular Imaging. 28: 1763-74. PMID 22147107 DOI: 10.1007/S10554-011-9995-Y  0.248
2021 Gündel D, Sadeghzadeh M, Deuther-Conrad W, Wenzel B, Cumming P, Toussaint M, Ludwig FA, Moldovan RP, Kranz M, Teodoro R, Sattler B, Sabri O, Brust P. Preclinical Evaluation of [F]FACH in Healthy Mice and Piglets: An F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET. International Journal of Molecular Sciences. 22. PMID 33562048 DOI: 10.3390/ijms22041645  0.248
2020 Marton J, Cumming P, Bauer B, Henriksen G. A new Precursor for the Radiosynthesis of 6-O-(2-[18F]Fluoroethyl)-6-O-desmethyl-diprenorphine ([18F]FE-DPN) by Nucleophilic Radiofluorination Letters in Organic Chemistry. 17. DOI: 10.2174/1570178617999200719153812  0.247
2013 Uebleis C, Hoyer X, Van Kriekinge SD, Schuessler F, Laubender RP, Becker A, Lehner S, Todica A, Haug A, Bartenstein P, Cumming P, Germano G, Hacker M. Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 20: 253-61. PMID 23354659 DOI: 10.1007/S12350-013-9673-7  0.243
1987 Cumming P, Boyes BE, Martin WR, Adam M, Grierson J, Ruth T, McGeer EG. The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat. Journal of Neurochemistry. 48: 601-8. PMID 3098920 DOI: 10.1111/J.1471-4159.1987.Tb04135.X  0.237
2012 Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1561-9. PMID 22752450 DOI: 10.1007/S00259-012-2157-1  0.237
2023 Cumming P, Dias AH, Gormsen LC, Hansen AK, Alberts I, Rominger A, Munk OL, Sari H. Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling. Ejnmmi Research. 13: 104. PMID 38032409 DOI: 10.1186/s13550-023-01049-3  0.236
2022 Sari H, Eriksson L, Mingels C, Alberts I, Casey ME, Afshar-Oromieh A, Conti M, Cumming P, Shi K, Rominger A. Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [F]-FDG datasets from a long axial FOV PET scanner. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36192468 DOI: 10.1007/s00259-022-05983-7  0.233
1991 Reith J, Benkelfat C, Kuwabara H, Savard G, Chouinard G, Andermann F, Sherwin A, Dyve S, Cumming P, Lal S, Etienne P, Bachneff S, Gjedde A. Elevated caudate DOPA decarboxylase activity in vivo in schizophrenia and temporal lobe epilepsy with psychosis European Neuropsychopharmacology. 1: 472. DOI: 10.1016/0924-977X(91)90697-S  0.233
2022 Völter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M, Barthel H, Katzdobler S, Palleis C, Franzmeier N, Levin J, Perneczky R, Rauchmann BS, Sabri O, Hong J, ... Cumming P, et al. Assessment of perfusion deficit with early phases of [F]PI-2620 tau-PET versus [F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36572740 DOI: 10.1007/s00259-022-06087-y  0.231
2023 Mohammadi Z, Alizadeh H, Marton J, Cumming P. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET. Biomolecules. 13. PMID 36830659 DOI: 10.3390/biom13020290  0.231
2021 Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K, Focke C, Sacher C, Wind K, Schmidt C, Lindner S, ... ... Cumming P, et al. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics. 11: 8964-8976. PMID 34522221 DOI: 10.7150/thno.64022  0.23
2016 Ilhan H, Wang H, Gildehaus FJ, Wängler C, Herrler T, Todica A, Schlichtiger J, Cumming P, Bartenstein P, Hacker M, Haug AR. Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy. Ejnmmi Research. 6: 64. PMID 27515447 DOI: 10.1186/S13550-016-0219-2  0.228
2017 Sai CY, Mokhtar N, Arof H, Cumming P, Iwahashi M. Automated Classification and Removal of EEG Artifacts with SVM and Wavelet-ICA. Ieee Journal of Biomedical and Health Informatics. PMID 28692997 DOI: 10.1109/Jbhi.2017.2723420  0.226
2018 Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G. Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion. Neuropsychiatric Disease and Treatment. 14: 1125-1138. PMID 29731635 DOI: 10.2147/Ndt.S148557  0.225
2022 Sari H, Mingels C, Alberts I, Hu J, Buesser D, Shah V, Schepers R, Caluori P, Panin V, Conti M, Afshar-Oromieh A, Shi K, Eriksson L, Rominger A, Cumming P. First results on kinetic modelling and parametric imaging of dynamic F-FDG datasets from a long axial FOV PET scanner in oncological patients. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34981164 DOI: 10.1007/s00259-021-05623-6  0.224
2022 Eggerstorfer B, Kim JH, Cumming P, Lanzenberger R, Gryglewski G. Meta-analysis of molecular imaging of translocator protein in major depression. Frontiers in Molecular Neuroscience. 15: 981442. PMID 36226319 DOI: 10.3389/fnmol.2022.981442  0.224
2015 Geisler S, Beindorff N, Cremer M, Hoffmann K, Brenner W, Cumming P, Meyer PT, Langen KJ, Fuchs E, Buchert R. Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography Synapse. DOI: 10.1002/syn.21838  0.224
2015 Veselinovi? T, Vernaleken I, Janouschek H, Kellermann T, Paulzen M, Cumming P, Gründer G. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers. Psychopharmacology. 232: 1607-17. PMID 25373869 DOI: 10.1007/S00213-014-3794-9  0.223
2024 Marešová A, Jurášek M, Drašar PB, Dolenský B, Prokudina EA, Shalgunov V, Herth MM, Cumming P, Popkov A. A facile synthesis of precursor for the σ-1 receptor PET radioligand [ F]FTC-146 and its radiofluorination. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 38171540 DOI: 10.1002/jlcr.4081  0.221
1995 Kuwabara H, Cumming P, Yasuhara Y, Léger GC, Guttman M, Diksic M, Evans AC, Gjedde A. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 1226-31. PMID 7790948  0.219
2021 Joo YH, Lee MW, Son YD, Chang KA, Yaqub M, Kim HK, Cumming P, Kim JH. In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [C]PK11195 PET Study. Biomedicines. 10. PMID 35052718 DOI: 10.3390/biomedicines10010034  0.216
2006 Jakobsen S, Pedersen K, Smith DF, Jensen SB, Munk OL, Cumming P. Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 2008-15. PMID 17138744  0.216
2020 Kim JH, Marton J, Ametamey SM, Cumming P. A Review of Molecular Imaging of Glutamate Receptors. Molecules (Basel, Switzerland). 25. PMID 33081223 DOI: 10.3390/molecules25204749  0.215
1996 Li BY, Nalwalk JW, Barker LA, Cumming P, Parsons ME, Hough LB. Characterization of the antinociceptive properties of cimetidine and a structural analog. The Journal of Pharmacology and Experimental Therapeutics. 276: 500-8. PMID 8632315  0.21
2016 Adam A, Ibrahim Z, Mokhtar N, Shapiai MI, Cumming P, Mubin M. Evaluation of different time domain peak models using extreme learning machine-based peak detection for EEG signal. Springerplus. 5: 1036. PMID 27462484 DOI: 10.1186/S40064-016-2697-0  0.209
1991 Brown EE, Damsma G, Cumming P, Fibiger HC. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. Journal of Neurochemistry. 57: 701-7. PMID 1906527 DOI: 10.1111/j.1471-4159.1991.tb03802.x  0.206
2009 Uebleis C, Becker A, Griesshammer I, Cumming P, Becker C, Schmidt M, Bartenstein P, Hacker M. Stable coronary artery disease: prognostic value of myocardial perfusion SPECT in relation to coronary calcium scoring--long-term follow-up. Radiology. 252: 682-90. PMID 19703866 DOI: 10.1148/Radiol.2531082137  0.206
2012 Nielsen MS, Andersen F, Cumming P, Møller A, Gjedde A, Sørensen JC, Bjarkam CR. Subthalamic high-frequency deep brain stimulation evaluated by positron emission tomography in a porcine Parkinson model Deep Brain Stimulation: New Developments, Procedures and Applications. 141-157.  0.205
2012 Nielsen MS, Andersen F, Cumming P, Møller A, Gjedde A, Sørensen JC, Bjarkam CR. Subthalamic high-frequency deep brain stimulation evaluated by positron emission tomography in a porcine Parkinson model Deep Brain Stimulation: New Developments, Procedures and Applications. 141-157.  0.205
2022 Mohamed AZ, Cumming P, Nasrallah FA. Escalation of Tau Accumulation after a Traumatic Brain Injury: Findings from Positron Emission Tomography. Brain Sciences. 12. PMID 35884683 DOI: 10.3390/brainsci12070876  0.201
2019 SAI CY, MOKHTAR N, YIP HW, BAK LLM, HASAN MS, AROF H, CUMMING P, MAT ADENAN NA. Objective identification of pain due to uterine contraction during the first stage of labour using continuous EEG signals and SVM SāDhanā. 44. DOI: 10.1007/S12046-019-1058-4  0.2
2020 Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F, Sacher C, Beyer L, Ruch-Rubinstein F, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Cumming P, Bartenstein P, Rominger A, et al. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Journal of Neuroinflammation. 17: 374. PMID 33317543 DOI: 10.1186/s12974-020-02046-2  0.2
2017 Adam A, Ibrahim Z, Mokhtar N, Shapiai MI, Cumming P, Mubin M. Improving EEG signal peak detection using feature weight learning of a neural network with random weights for eye event-related applications SāDhanā. 42: 641-653. DOI: 10.1007/S12046-017-0633-9  0.2
2018 Smirnova D, Cumming P, Sloeva E, Kuvshinova N, Romanov D, Nosachev G. Language Patterns Discriminate Mild Depression From Normal Sadness and Euthymic State. Frontiers in Psychiatry. 9: 105. PMID 29692740 DOI: 10.3389/Fpsyt.2018.00105  0.199
2019 Laesser CI, Cumming P, Reber E, Stanga Z, Muka T, Bally L. Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review. Journal of Clinical Medicine. 8. PMID 31261760 DOI: 10.3390/Jcm8070935  0.199
2021 Ripp IK, Wallenwein LA, Wu Q, Emch M, Koch K, Cumming P, Yakushev I. Working memory task induced neural activation: a simultaneous PET/fMRI study. Neuroimage. 118131. PMID 33951511 DOI: 10.1016/j.neuroimage.2021.118131  0.198
2008 Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria (Journal of Cerebral Blood Flow and Metabolism (2008) 28 (824-831) DOI: doi: 10.1038/sj.jcbfm.9600571) Journal of Cerebral Blood Flow and Metabolism. 28: 1070. DOI: 10.1038/sj.jcbfm.9600588  0.197
2021 Joo YH, Kim JH, Kim HK, Son YD, Cumming P, Kim JH. Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study. Life (Basel, Switzerland). 11. PMID 34070900 DOI: 10.3390/life11060506  0.193
2022 Hoareau R, Bach-Gansmo T, Cumming P, Olberg DE. A new automated and putatively versatile synthesis of the PSMA-ligand derivative [F]DCFPyL using the FASTlab synthesizer. Ejnmmi Radiopharmacy and Chemistry. 7: 10. PMID 35507241 DOI: 10.1186/s41181-022-00157-0  0.189
2015 Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment. Molecular Psychiatry. 20: 1179-87. PMID 26055427 DOI: 10.1038/mp.2015.74  0.187
2014 Lehner S, Todica A, Vanchev Y, Uebleis C, Wang H, Herrler T, Wängler C, Cumming P, Böning G, Franz WM, Bartenstein P, Hacker M, Brunner S. In Vivo Monitoring of Parathyroid Hormone Treatment after Myocardial Infarction in Mice with [(68)Ga]Annexin A5 and [(18)F]Fluorodeoxyglucose Positron Emission Tomography. Molecular Imaging. 13: 7290201400035. PMID 28650296 DOI: 10.2310/7290.2014.00035  0.187
2014 Amato D, Müller CP, Canneva F, Cumming P, Maschauer S, Quinger B, Prante O, von Hösten S, Kornhuber J. MECHANISMS OF ANTIPSYCHOTIC TRATMENT FAILURE Schizophrenia Research. 153: S69. DOI: 10.1016/S0920-9964(14)70224-5  0.186
2023 Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, ... ... Cumming P, et al. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37971501 DOI: 10.1007/s00259-023-06493-w  0.185
2021 Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, Bohn KP, Alberts I, Mingels C, Thurnher M, Cumming P, Shi K, Peters A, Geleff S, Lan X, Wang F, Huber A, Gräni C, et al. A comprehensive review of imaging findings in COVID-19 - status in early 2021. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33932183 DOI: 10.1007/s00259-021-05375-3  0.184
2021 Biechele G, Sebastian Monasor L, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus FJ, von Ungern-Sternberg B, Willem M, Bartenstein P, Cumming P, Rominger A, et al. Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34016733 DOI: 10.2967/jnumed.120.261858  0.184
2022 Blume T, Deussing M, Biechele G, Peters F, Zott B, Schmidt C, Franzmeier N, Wind K, Eckenweber F, Sacher C, Shi Y, Ochs K, Kleinberger G, Xiang X, Focke C, ... ... Cumming P, et al. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition. Frontiers in Aging Neuroscience. 14: 854031. PMID 35431893 DOI: 10.3389/fnagi.2022.854031  0.184
2021 Patkar OL, Mohamed AZ, Narayanan A, Mardon K, Cowin G, Bhalla R, Stimson DHR, Kassiou M, Beecher K, Belmer A, Alvarez Cooper I, Morgan M, Hume DA, Irvine KM, Bartlett SE, ... ... Cumming P, et al. A binge high sucrose diet provokes systemic and cerebral inflammation in rats without inducing obesity. Scientific Reports. 11: 11252. PMID 34045616 DOI: 10.1038/s41598-021-90817-z  0.182
2019 Zhao Y, Cumming P, Rominger A, Zuo C, Shi K, Wu P, Wang J, Li H, Navab N, Yakushev I, Weber W, Schwaiger M, Huang SC. A 3D Deep Residual Convolutional Neural Network for Differential Diagnosis of Parkinsonian Syndromes on F-FDG PET Images. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2019: 3531-3534. PMID 31946640 DOI: 10.1109/EMBC.2019.8856747  0.182
2023 Németh E, Gyuricza B, Forgács V, Cumming P, Henriksen G, Marton J, Bauer B, Mikecz P, Fekete A. Optimization of a Nucleophilic Two-Step Radiosynthesis of 6--(2-[F]fluoroethyl)-6--desmethyl-diprenorphine ([F]FE-DPN) for PET Imaging of Brain Opioid Receptors. International Journal of Molecular Sciences. 24. PMID 37685958 DOI: 10.3390/ijms241713152  0.181
2015 Cumming P, Hartvig-Honoré P. Chapter 26: An overview of PET studies of the cerebral uptake of amino acids Targeting the Broadly Pathogenic Kynurenine Pathway. 339-355. DOI: 10.1007/978-3-319-11870-3_26  0.179
2009 Cumming P. Imaging dopamine Imaging Dopamine. 1-360. DOI: 10.1017/CBO9780511575853  0.178
1999 Thompson CJ, Sciascia P, Murthy K, Kecani S, Nikkinen L, del Campo E, Corbett JF, Bercier Y, Diksic M, Cumming P. 'ANIPET' a versatile PET scanner for imaging small animals Ieee Nuclear Science Symposium and Medical Imaging Conference. 2: 1264-1267.  0.172
1992 Cumming P. No politics please Nature. 357: 432-432. DOI: 10.1038/357432D0  0.168
2020 Joo YH, Kim YK, Choi IG, Kim HJ, Son YD, Kim HK, Cumming P, Kim JH. In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [F]FDG microPET and MRS. Ejnmmi Research. 10: 116. PMID 33006705 DOI: 10.1186/s13550-020-00716-z  0.16
2014 Cumming P. Not shooting an elephant. Neuroimage. 94: 411-2. PMID 24555952 DOI: 10.1016/J.Neuroimage.2014.02.012  0.159
2023 To XV, Donnelly P, Maclachlan L, Mahady K, Apellaniz EM, Cumming P, Winter C, Nasrallah F. Anti-inflammatory interleukin 1 receptor antagonist concentration in plasma correlates with blood-brain barrier integrity in the primary lesion area in traumatic brain injury patients. Brain, Behavior, & Immunity - Health. 31: 100653. PMID 37415924 DOI: 10.1016/j.bbih.2023.100653  0.158
2023 To XV, Mohamed AZ, Cumming P, Nasrallah FA. Association of sub-acute changes in plasma amino acid levels with long-term brain pathologies in a rat model of moderate-severe traumatic brain injury. Frontiers in Neuroscience. 16: 1014081. PMID 36685246 DOI: 10.3389/fnins.2022.1014081  0.155
2021 Mohamed AZ, Cumming P, Nasrallah FA. Traumatic brain injury augurs ill for prolonged deficits in the brain's structural and functional integrity following controlled cortical impact injury. Scientific Reports. 11: 21559. PMID 34732737 DOI: 10.1038/s41598-021-00660-5  0.152
2015 Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET. Molecular Psychiatry. 20: 1141. PMID 26401838 DOI: 10.1038/mp.2015.146  0.152
2021 Gründer G, Cumming P. Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease". Journal of Neurochemistry. PMID 33459383 DOI: 10.1111/jnc.15269  0.146
2022 Vinh To X, Mohamed AZ, Cumming P, Nasrallah FA. Subacute cytokine changes after a traumatic brain injury predict chronic brain microstructural alterations on advanced diffusion imaging in the male rat. Brain, Behavior, and Immunity. 102: 137-150. PMID 35183698 DOI: 10.1016/j.bbi.2022.02.017  0.141
2021 Mohamed AZ, Nestor PJ, Cumming P, Nasrallah FA. Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging. Journal of Neurology. PMID 34191080 DOI: 10.1007/s00415-021-10669-5  0.14
2023 Kiilerich KF, Lorenz J, Scharff MB, Speth N, Brandt TG, Czurylo J, Xiong M, Jessen NS, Casado-Sainz A, Shalgunov V, Kjaerby C, Satała G, Bojarski AJ, Jensen AA, Herth MM, ... Cumming P, et al. Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. Molecular Psychiatry. PMID 37783788 DOI: 10.1038/s41380-023-02280-z  0.138
2010 Förster S, Rominger A, Saam T, Wolpers S, Nikolaou K, Cumming P, Reiser MF, Bartenstein P, Hacker M. 18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study. Nuklearmedizin. Nuclear Medicine. 49: 148-53. PMID 20532464 DOI: 10.3413/nukmed-0299  0.138
2015 Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment Molecular Psychiatry. DOI: 10.1038/mp.2015.74  0.136
2021 Kopishinskaia S, Cumming P, Karpukhina S, Velichko I, Raskulova G, Zheksembaeva N, Tlemisova D, Morozov P, Fountoulakis KN, Smirnova D. Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: Incidental findings or cause for alarm? Asian Journal of Psychiatry. 63: 102761. PMID 34271538 DOI: 10.1016/j.ajp.2021.102761  0.132
2021 Kopishinskaia S, Cumming P, Karpukhina S, Velichko I, Raskulova G, Zheksembaeva N, Tlemisova D, Morozov P, Fountoulakis KN, Smirnova D. Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: Incidental findings or cause for alarm? Asian Journal of Psychiatry. 63: 102761. PMID 34271538 DOI: 10.1016/j.ajp.2021.102761  0.132
2020 Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Tahirovic S, Willem M, Bartenstein P, ... Cumming P, et al. Microglial Activation in the Right Amygdala-Entorhinal-Hippocampal Complex is Associated with Preserved Spatial Learning in App mice. Neuroimage. 117707. PMID 33385560 DOI: 10.1016/j.neuroimage.2020.117707  0.13
2024 To XV, Mohamed AZ, Cumming P, Nasrallah FA. Diffusion tensor imaging and plasma immunological biomarker panel in a rat traumatic brain injury (TBI) model and in human clinical TBI. Frontiers in Immunology. 14: 1293471. PMID 38259455 DOI: 10.3389/fimmu.2023.1293471  0.13
2012 Cumming P, Vasdev N. The assay of enzyme activity by positron emission tomography Neuromethods. 71: 111-135. DOI: 10.1007/7657-2012-53  0.129
2013 Yakushev I, Förster S, Cumming P. Task- versus amphetamine-induced displacement of high-affinity D2/3 receptor ligands. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1849. PMID 23781012 DOI: 10.2967/jnumed.112.117564  0.129
2023 To XV, Vegh V, Owusu-Amoah N, Cumming P, Nasrallah FA. Hippocampal demyelination is associated with increased magnetic susceptibility in a mouse model of concussion. Experimental Neurology. 365: 114406. PMID 37062352 DOI: 10.1016/j.expneurol.2023.114406  0.128
2021 Penzel N, Antonucci LA, Betz LT, Sanfelici R, Weiske J, Pogarell O, Cumming P, Quednow BB, Howes O, Falkai P, Upthegrove R, Bertolino A, Borgwardt S, Brambilla P, Lencer R, et al. Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33658653 DOI: 10.1038/s41386-021-00977-9  0.121
2022 Berlowitz I, Egger K, Cumming P. Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca. Frontiers in Pharmacology. 13: 886408. PMID 35600851 DOI: 10.3389/fphar.2022.886408  0.115
2021 Mohamed AZ, Cumming P, Nasrallah FA. White-matter alterations are associated with cognitive dysfunction decades following moderate-to-severe traumatic brain injury and/or post-traumatic stress disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 33957321 DOI: 10.1016/j.bpsc.2021.04.014  0.111
2023 Vinh To X, Kurniawan ND, Cumming P, Nasrallah FA. A cross-comparative analysis of in vivo versus ex vivo MRI indices in a mouse model of concussion. Brain Research. 1820: 148562. PMID 37673379 DOI: 10.1016/j.brainres.2023.148562  0.108
2007 Vafaee MS, Borghammer P, Aanerud J, Cumming P, Gjedde A. Cerebral blood flow, cerebral oxygen metabolism, and atrophy in healthy aging Journal of Cerebral Blood Flow and Metabolism. 27: BP31-04W.  0.1
2014 Brust P, Deuther-Conrad W, Donat CK, Barthel H, Riss P, Paterson L, Höpping A, Sabri O, Cumming P. Preclinical aspects of nicotinic acetylcholine receptor imaging Pet and Spect of Neurobiological Systems. 465-512. DOI: 10.1007/978-3-642-42014-6_17  0.098
2022 Fathabadipour S, Mohammadi Z, Roshani F, Goharbakhsh N, Alizadeh H, Palizgar F, Cumming P, Michel TM, Vafaee MS. The neural effects of oxytocin administration in autism spectrum disorders studied by fMRI: A systematic review. Journal of Psychiatric Research. 154: 80-90. PMID 35933858 DOI: 10.1016/j.jpsychires.2022.06.033  0.083
2022 Penzel N, Sanfelici R, Antonucci LA, Betz LT, Dwyer D, Ruef A, Cho KIK, Cumming P, Pogarell O, Howes O, Falkai P, Upthegrove R, Borgwardt S, Brambilla P, Lencer R, et al. Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis. Npj Schizophrenia. 8: 19. PMID 35264631 DOI: 10.1038/s41537-022-00218-y  0.082
2022 Vaiman EE, Shnayder NA, Zhuravlev NM, Petrova MM, Asadullin AR, Al-Zamil M, Garganeeva NP, Shipulin GA, Cumming P, Nasyrova RF. Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia. International Journal of Molecular Sciences. 23. PMID 36555428 DOI: 10.3390/ijms232415786  0.081
2022 Dobrodeeva V, Abdyrahmanova A, Astafeva D, Smirnova D, Cumming P, De Sousa A, Davydkin I, Yashikhina A, Shnayder N, Nasyrova R. Pharmacogenetic Aspects of COVID-19 Management and Post-COVID-19 Depression Treatment with Fluvoxamine. Psychiatria Danubina. 34: 25-30. PMID 36170697  0.079
2022 Marton J, Fekete A, Cumming P, Hosztafi S, Mikecz P, Henriksen G. Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations. Molecules (Basel, Switzerland). 27. PMID 35566212 DOI: 10.3390/molecules27092863  0.068
2023 Chigareva O, Smirnova D, Astafeva D, Gradinar A, Izmailova O, Sheyfer M, Cumming P, Sack A, Gayduk AJ. Comparing the Anti-Depressive Effect of Electroconvulsive Therapy (ECT) Versus Transcranial Magnetic Stimulation (TMS) in the Treatment of Patients with Depression. Psychiatria Danubina. 35: 48-55. PMID 37800203  0.064
2023 Mercolli L, Mingels C, Manzini G, Cumming P, Zeimpekis K, Xue S, Alberts I, Uehlinger D, Rominger A, Shi K, Afshar-Oromieh A. [Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37620052 DOI: 10.2967/jnumed.123.265577  0.06
1999 Baggaley MR, Piper ME, Cumming P, Murphy G. Trauma related symptoms in British soldiers 36 months following a tour in the former Yugoslavia. Journal of the Royal Army Medical Corps. 145: 13-4. PMID 10216840  0.059
2023 Gayduk AJ, Syunyakov T, Gazheva AV, Strelnik A, Chigareva O, Kuznetsov A, Kokorev D, Sustretov A, Cumming P, Vlasov YV. Neurological and Psychiatric Aspects of Biological Markers for the Provision of Medical Care to Patients with Spinal Muscular Atrophy 5q. Psychiatria Danubina. 35: 322-328. PMID 37800249  0.059
2022 Vaiman E, Gayduk A, Strelnik A, Smirnova D, Davydkin I, Fedyashov I, Cumming P, Shnayder N, Nasyrova R. Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression. Psychiatria Danubina. 34: 31-37. PMID 36170698  0.054
2012 Cumming P, Vasdev N. Molecular imaging studies of second messenger pathways: Looking deeper than the membrane Neuromethods. 71: 137-148. DOI: 10.1007/7657-2012-52  0.05
2010 Vernaleken I, Gruender G, Cumming P. Progress in Psychopharmacotherapy though Molecular Imaging Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling. 189-206. DOI: 10.1002/9783527630271.ch9  0.05
2007 Katz LM, Cumming PD, Wallace EL. Computer-based blood donor screening: a status report. Transfusion Medicine Reviews. 21: 13-25. PMID 17174217 DOI: 10.1016/j.tmrv.2006.08.001  0.048
1975 Pegels CC, Seagle JP, Cumming PD, Kendall KE. A computer-based interactive planning system for scheduling blood collections. Transfusion. 15: 381-6. PMID 1166512  0.044
2022 Borisova N, Moore N, Sira Mahalingappa S, Cumming P, Dave S, Abraham S, Ramkisson R, Tavormina G, Kolsanov A, Chaplygin S, Kozina T, Vlasov A, Smirnova D, Syunyakov T. Virtual Reality-Based Interventions for Treating Depression in the Context of COVID-19 Pandemic: Inducing the Proficit in Positive Emotions as a Key Concept of Recovery and a Path Back to Normality. Psychiatria Danubina. 34: 276-284. PMID 36170742  0.043
1977 Cumming PD, Kendall KE, Pegels CC, Seagle JP. Cost effectiveness of use of frozen blood to alleviate blood shortages. Transfusion. 17: 602-6. PMID 413224  0.043
2019 Smirnova D, Romanov D, Sloeva E, Kuvshinova N, Cumming P, Nosachev G. Language in Mild Depression: How It Is Spoken, What It Is About, and Why It Is Important to Listen. Psychiatria Danubina. 31: 427-433. PMID 31488766  0.042
1989 Cumming PD, Wallace EL, Schorr JB, Dodd RY. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative. The New England Journal of Medicine. 321: 941-6. PMID 2779616 DOI: 10.1056/NEJM198910053211405  0.037
2022 Gayduk AJ, Shishkovskaia TI, Cumming P, Koutsomitros T, Sack AT, Vlasov YV, Smirnova D. Association between Neuropathic Pain and Depression: Focusing on the Transcranial Magnetic Stimulation As a Promising Treatment Approach. Psychiatria Danubina. 34: 105-111. PMID 36170712  0.036
2005 Katz LM, Cumming PD, Wallace EL, Abrams PS. Audiovisual touch-screen computer-assisted self-interviewing for donor health histories: results from two years experience with the system. Transfusion. 45: 171-80. PMID 15660824 DOI: 10.1111/j.1537-2995.2004.04020.x  0.035
1984 Katz AJ, Cumming PD, Sandler SG, Berkowitz A. The impact of AIDS on the voluntary blood donor system: a preliminary analysis. Annals of the New York Academy of Sciences. 437: 487-92. PMID 6598312  0.033
2022 Astafeva D, Kolsanov A, Chaplygin S, Yashikhina A, Cumming P, Vlasov A, Syunyakov T, Smirnova D. The Efficacy of Mobile Phone-Based Interventions for the Treatment of Depression: A Systematic Meta-Review of Meta-Analyses of Randomized Controlled Trials. Psychiatria Danubina. 34: 155-163. PMID 36170722  0.031
2016 Cumming P. A business of some heat: Molecular imaging of phosphodiesterase 5 Journal of Neurochemistry. 136: 220-221. DOI: 10.1111/jnc.13453  0.031
2001 Zuck TF, Cumming PD, Wallace EL. Computer-assisted audiovisual health history self-interviewing. Results of the pilot study of the Hoxworth Quality Donor System. Transfusion. 41: 1469-74. PMID 11778058  0.03
2022 Germanova O, Smirnova D, Usenova A, Tavormina G, Cumming P, Galati G. Cryptogenic Stroke In The Context of Pandemic-Related Stress: The Role of Arterial Hemodynamics. Psychiatria Danubina. 34: 256-261. PMID 36170739  0.029
2001 Paul F, Cumming P, Fleck E. Patient information: involving the user group. Professional Nurse (London, England). 16: 1405-8. PMID 12026859  0.027
2011 Cumming PE. Fixing stories "is sure a lot of work": Watching "the men's dance" in medicine river and green grass, running water Making It Like a Man: Canadian Masculinities in Practice. 171-184.  0.027
1977 Pegels CC, Seagle JP, Cumming PC, Kendall KE, Shubsda JF. An analysis of selected blood service policy changes. Medical Care. 15: 147-57. PMID 839869  0.027
1963 CUMMING GR, CUMMING PM. Working capacity of normal children tested on a bicycle ergometer. Canadian Medical Association Journal. 88: 351-5. PMID 14024227  0.027
2023 Kuznetsov A, Kokorev D, Sustretov A, Kozlov A, Lyamin A, Sheyfer M, Kolsanov A, DeSousa A, Cumming P, Gayduk A. Genetic Contributors to PTSD: the Role of SNVs, Gene Interactions and Haplotypes for Developing PTSD Prevention Measures. A Comprehensive Review. Psychiatria Danubina. 35: 141-149. PMID 37800217  0.026
1998 Finnegan AP, Cumming PA, Piper ME. Critical incident stress debriefing following the terrorist bombing at Army Headquarters Northern Ireland. Journal of the Royal Army Medical Corps. 144: 5-10. PMID 9694008  0.024
1997 Cumming P, Gjedde A, Reith J. Controversies arising from recent FDOPA articles. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 1267-71. PMID 9255163  0.023
2014 Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S, Cumming P, Liao XH, Ryan M, Harker D, Stevens G, Rogers N, Blanks R, et al. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. British Journal of Cancer. 110: 560-4. PMID 24366303 DOI: 10.1038/bjc.2013.778  0.015
1974 Cumming PD, Wallace EL, Surgenor DM, Mierzwa BD, Smith FA. Public interest pricing of blood services. Medical Care. 12: 743-53. PMID 4415380 DOI: 10.1097/00005650-197409000-00002  0.014
1985 Schorr JB, Berkowitz A, Cumming PD, Katz AJ, Sandler SG. Prevalence of HTLV-III antibody in American blood donors. The New England Journal of Medicine. 313: 384-5. PMID 3859750 DOI: 10.1056/NEJM198508083130610  0.014
1973 Surgenor DM, Wallace EL, Cumming PD, Mierzwa BD, Smith FA. Blood services: prices and public policy. Science (New York, N.Y.). 180: 384-9. PMID 4700598 DOI: 10.1126/SCIENCE.180.4084.384  0.01
Hide low-probability matches.